แท้วิริยะกุล อ, วรสาร เ, ฉันทแดนสุวรรณ ธ. Eligibility for PCSK9 Inhibitors and Associated Cost in Patient with Atherosclerotic Cardiovascular Disease at Central Chest Institute of Thailand. Thai J Clin Pharm [Internet]. 2023Apr.26 [cited 2024Jul.22];29(1):65-73. Available from: https://thaidj.org/index.php/TJCP/article/view/13339